355 studies found for:    Cord blood | Open Studies | Exclude Unknown
Show Display Options
Rank Status Study
1 Recruiting Cord Blood Infusion for Ischemic Stroke
Condition: Stroke
Intervention: Biological: allogeneic umbilical cord blood
2 Recruiting Donor Umbilical Cord Blood Transplant With or Without Ex-Vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
Conditions: Acute Biphenotypic Leukemia;   Acute Lymphoblastic Leukemia in Remission;   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;   Acute Myeloid Leukemia in Remission;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Mixed Phenotype Acute Leukemia;   Myelodysplastic Syndrome;   Pancytopenia;   Refractory Anemia;   Refractory Anemia With Excess Blasts;   Refractory Anemia With Excess Blasts in Transformation;   Secondary Acute Myeloid Leukemia
Interventions: Drug: Cyclophosphamide;   Drug: Cyclosporine;   Procedure: Double-Unit Umbilical Cord Blood Transplantation;   Procedure: Ex Vivo-Expanded Cord Blood Progenitor Cell Infusion;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Mycophenolate Mofetil;   Radiation: Total-Body Irradiation;   Procedure: Umbilical Cord Blood Transplantation
3 Recruiting Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure
Conditions: Hematopoietic Stem Cell Transplantation;   Mesenchymal Stem Cells;   Umbilical Cord Blood;   Graft Failure;   Hematological Diseases
Interventions: Biological: Mesenchymal stem cells;   Biological: Mesenchymal stem cells and cord blood
4 Recruiting Umbilical Cord Blood Transplant for Congenital Pediatric Disorders
Condition: Congenital Pediatric Disorders
Interventions: Drug: Busulfan;   Drug: Cytoxan;   Drug: Fludarabine;   Procedure: Cord Blood Stem Cell Infusion
5 Recruiting Umbilical Cord Blood Therapy for Global Developmental Delay
Condition: Global Developmental Delay
Intervention: Procedure: Umbilical Cord Blood administration
6 Recruiting New York Blood Center National Cord Blood Program
Conditions: Leukemia;   Lymphoma;   Genetic Disease;   Severe Aplastic Anemia;   Myelodysplasia
Intervention: Biological: Umbilical Cord Blood Transplantation
7 Recruiting Cord Blood Expansion on Mesenchymal Stem Cells
Conditions: Myelodysplastic Syndrome;   Leukemia
Interventions: Procedure: Cord Blood Infusion;   Drug: Busulfan;   Drug: Fludarabine;   Drug: Rituximab;   Other: ATG;   Drug: Cyclophosphamide;   Drug: Clofarabine;   Radiation: Total Body Irradiation  (TBI);   Drug: Melphalan;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil;   Drug: G-CSF
8 Recruiting Cord Blood Transplantation in Severe Aplastic Anemia
Conditions: Hereditary Diseases;   Acquired Aplastic Anemia;   Relapse;   Absence of an HLA Identical Donor
Intervention: Procedure: Cord Blood Transplantation
9 Recruiting The Collection and Storage of Umbilical Cord Blood for Transplantation
Conditions: Cord Blood Stem Cell Transplantation;   Cord Blood Transplantation;   Hematopoietic Stem Cell Transplantation
Intervention:
10 Recruiting Safety Study of Human Umbilical Cord Blood Monocyte in the Acute Ischemic Stroke Patients
Conditions: Acute Stroke;   Brain Ischemia;   Ischemia;   Infarction, Middle Cerebral Artery
Intervention: Biological: Intravenous Human Umbilical Cord Blood Monocyte
11 Recruiting Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
Condition: Neonatal Hypoxic Ischemic Encephalopathy
Interventions: Biological: infusion of autologous cord blood;   Other: Neurodevelopmental outcomes
12 Recruiting Clinical Efficacy of Platelet Gel From Cord Blood for the Treatment of Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Interventions: Biological: Allogeneic cord blood platelet gel-CBPG;   Other: Standard Local Medications-SLM
13 Recruiting Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children
Condition: Cerebral Palsy
Interventions: Biological: Cord Blood Infusion;   Biological: Intravenous Sham
14 Recruiting Cord Blood Fucosylation
Conditions: Blood And Marrow Transplantation;   Leukemia;   Lymphoma;   Transplantation Infection;   Transplantation, Bone Marrow
Interventions: Drug: Melphalan;   Drug: Fludarabine;   Drug: Mycophenolate mofetil;   Drug: Tacrolimus;   Procedure: Cord Blood Infusion;   Drug: Rituximab;   Drug: ATG;   Drug: Busulfan;   Drug: Clofarabine;   Radiation: Total Body Irradiation  (TBI)
15 Recruiting Clinical Trial to Evaluate the Potential Efficacy and Safety of Human Umbilical Cord Blood and Plasma
Condition: Aging
Interventions: Other: Fresh cord blood(experimental group A);   Other: Frozen cord blood(experimental group B);   Other: Frozen plasma(experimental group C);   Other: Placebo group
16 Recruiting Laboratory-Treated Donor Cord Blood Cell Infusion Following Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Acute Leukemias of Ambiguous Lineage;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Childhood Acute Myeloid Leukemia
Interventions: Biological: filgrastim;   Drug: fludarabine phosphate;   Drug: cytarabine;   Procedure: ex vivo-expanded cord blood progenitor cell infusion
17 Recruiting Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Aggressive Non-Hodgkin Lymphoma;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Indolent Non-Hodgkin Lymphoma;   Malignant Lymphoma, Large Cell Type;   Myelodysplastic Syndrome;   Myeloproliferative Neoplasm;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Follicular Lymphoma;   Recurrent Lymphoplasmacytic Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Plasma Cell Myeloma;   Recurrent Small Lymphocytic Lymphoma;   Recurrent T-Cell Non-Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Refractory Follicular Lymphoma;   Refractory Hodgkin Lymphoma;   Refractory Lymphoplasmacytic Lymphoma;   Refractory Mantle Cell Lymphoma;   Refractory Small Lymphocytic Lymphoma;   T-Cell Non-Hodgkin Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Cyclosporine;   Drug: Fludarabine Phosphate;   Drug: Mycophenolate Mofetil;   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Procedure: Umbilical Cord Blood Transplantation;   Radiation: Total-Body Irradiation;   Other: Laboratory Biomarker Analysis
18 Recruiting Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
Conditions: Lymphatic Diseases;   Hematopoietic Malignancy
Intervention: Biological: Umbilical Cord Blood (UCB)
19 Recruiting Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome
Condition: Hypoplastic Left Heart Syndrome
Intervention: Biological: Autologous Umbilical Cord Blood
20 Recruiting A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission
Condition: Leukemia
Intervention: Procedure: Transplantation of unrelated cord blood unit(s)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years